임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
35건 표시
- 1상모집 중· Staphylococcus Aureus Bloodstream InfectionA Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults
리드: 아스트라제네카
- 1상모집 중· Healthy ParticipantsA Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults
리드: 아스트라제네카
- 1상모집 중· Hepatic ImpairmentA Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
리드: 아스트라제네카
- 1상모집 중· Healthy ParticipantsA Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
리드: 아스트라제네카
- 1상모집 중· EGFR Mutation-positive NSCLCPhase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC
리드: 아스트라제네카
- 1상모집 중· Fallopian Tube CancerDrug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
리드: 아스트라제네카
- 1상모집 중· Moderate Hepatic ImpairmentA Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
리드: 아스트라제네카
- 1상모집 중· Healthy ParticipantsA Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants
리드: 아스트라제네카
- 1상모집 중· Multiple SclerosisAn Open-label Study of AZD0120 in Adults With Multiple Sclerosis
리드: 아스트라제네카
- 1상모집 중· Rheumatoid ArthritisStudy Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
리드: 아스트라제네카
- 1상모집 중· Healthy ParticipantsA Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
리드: 아스트라제네카
- 1상모집 중· Autosomal Dominant Polycystic Kidney DiseaseSafety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
리드: 아스트라제네카
- 1상모집 중· Haematologic NeoplasmsA Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
리드: 아스트라제네카
- 1상모집 중· Recurrent or Metastatic Solid TumorsA Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
협력: 아스트라제네카
- 1상모집 중· Chronic Kidney DiseaseA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
리드: 아스트라제네카
- 1상모집 중· Biliary Tract CancersTargeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
협력: 아스트라제네카
- 1상모집 중· Locally Advanced or Metastatic Solid TumorAZD5305 hADME in Patients With Advanced Solid Malignancies
리드: 아스트라제네카
- 1상모집 중· Metastatic Castration-Resistant Prostate CancerA Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
리드: 아스트라제네카
- 1상모집 중· Non-small Cell Lung CancerPhase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
리드: 아스트라제네카
- 1상모집 중· Non-small Cell Lung CancerA Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
리드: 아스트라제네카
- 1상모집 중· Advanced Solid TumorA Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
협력: 아스트라제네카
- 1상모집 중· Resectable Hepatocellular CarcinomaSIRT With Tremelimumab and Durvalumab for Resectable HCC
협력: 아스트라제네카
- 1상모집 중· Locally Advanced or Metastatic Non-Small Cell Lung CancerPhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
리드: 아스트라제네카
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.